Related Experiment Video
Updated: Jan 29, 2026

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases
Susan L Baldwin1, Sasha E Larsen1,2, Diane Ordway3
1Infectious Disease Research Institute, Seattle, Washington, United States of America.
Abstract:
Seemingly innocuous nontuberculous mycobacteria (NTM) species, classified by their slow or rapid growth rates, can cause a wide range of illnesses, from skin ulceration to severe pulmonary and disseminated disease. Despite their worldwide prevalence and significant disease burden, NTM do not garner the same financial or research focus as Mycobacterium tuberculosis. In this review, we outline the most abundant of over 170 NTM species and inadequacies of diagnostics and treatments and weigh the advantages and disadvantages of currently available in vivo animal models of NTM. In order to effectively combat this group of mycobacteria, more research focused on appropriate animal models of infection, screening of chemotherapeutic compounds, and development of anti-NTM vaccines and diagnostics is urgently needed.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Cancer Prevention
Some...
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Prevention of Further Absorption of Poison
Preventive Healthcare Services
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...

